Drug Approval | August 06, 2021
India’s gets its first bio-bank for heart failure research
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Robust demand for the product across the Middle East, Africa and Latin America
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
The country has constantly worked with the spirit of public-private partnership
Subscribe To Our Newsletter & Stay Updated
